Bottom line
What is BIGRX's expense ratio?
BIGRX's expense ratio is 0.66%, or about $66 a year on every $10,000 invested. That is cheaper than 67% of large value funds we track (median 0.81%). It has no front-end sales load.
Updated Oct 28, 2026
BIGRX fee table
| Net expense ratio | 0.66% |
|---|---|
| Gross expense ratio | 0.66% |
| Management fee | 0.65% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.01% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Oct 28, 2026
What BIGRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| BIGRX | $68 | $212 | $368 | $823 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.66% expense ratio costs roughly $37,700 in lost growth, versus about $45,600 for the median large value fund (0.81%).
Cheaper alternatives to BIGRX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
| Fund | Expense ratio | Saves per year | Saves over 20 yrs* | Overlap |
|---|---|---|---|---|
| TVAL T. Rowe Price | 0.33% | $33 | $1,827 | 51% |
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.